Synaffix and MacroGenics expand ADC partnership
The expanded antibody-drug conjugate (ADC) collaboration includes up to $2.2bn in total potential payments plus tiered royalties on net sales.
Archives for March 14, 2023
Neurodegenerative disease focused Teitur Trophics raises €28m in Series A financing
Teitur Trophics, a startup looking to prevent the death of neurons in neurodegenerative diseases, has completed a €28m (US$29.9m) Series A financing round co-led by Sunstone Life Science Ventures and Sound Bioventures.
Moderna to hire 2,000 new employees in 2023: 'We are making significant investments in both people and infrastructure to build the most impactful version of Moderna.'
Moderna will expand in the US with new offices in San Francisco and Seattle: while the company also expects to hire around 2,000 new employees globally this year.
UK boosts cell and gene therapy manufacturing with new facility
The new Clinical Biotechnology Centre (CBC) in Bristol will expand the UK’s ability to make clinical grade products for the research and development of new cell and gene therapies.
Grifols and Selagine collaborate to produce 'game-changing' dry eye disease treatment
Grifols has entered into a collaboration and licensing agreement with Selagine to develop immunoglobulin (Ig) eye drops to treat dry eye disease.